Riskpilot
← Back to search
Sign in
Get full access
Termino C 14110 AB
AB
Dissolved
Org 5592407125
Manufacture of irradiation, electromedical and electrotherapeutic equipment
· NACE 2660
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of irradiation, electromedical and electrotherapeutic equipment
/
Termino C 14110 AB
Overview
Financials
People & ownership
Related companies
Loading company…
Revenue 2024
SEK 0
EBITDA margin
—
0% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -11K
0% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -12K
+0%
Net profit
SEK -11K
+0%
Total assets
SEK 30K
-69%
Equity
SEK 30K
-27%
Employees
0
—
Company information
Legal name
Termino C 14110 AB
Org number
5592407125
Legal form
Aktiebolag
NACE code
2660 ·
Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
5 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of irradiation, electromedical and electrotherapeutic equipment
Companies in Vaxholm
All Sweden companies
Frequently asked questions
What is the Org number of Termino C 14110 AB?
Termino C 14110 AB is registered with Bolagsverket / SCB under Org 5592407125.
Who is the CEO of Termino C 14110 AB?
Ingela Marika Eriksson is Authorized Recipient of Service of Termino C 14110 AB, in role since 2025.
Who is the chairman of Termino C 14110 AB?
Anders Jakob Lindquist chairs the board of Termino C 14110 AB, in role since 2025.
